TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03081117

Intranasal Insulin for the Treatment of HAND

Cause of deathStaffing, sites or logistics, also safety Automatic label, confidence 0.5, unverified. How labels are made.
“On 3/15/2020 study visits were suspended due to COVID-19 pandemic. With safety concerns surrounding COVID-19 and difficulty recruiting, the investigators decided to close enrollment 10/16/2020 after interim data were reviewed by the DSMB and NIH.”

The sponsor’s own words in the registry.

Life of this trial

201720182019202020212022Registered2017-03-09Started2017-08-01Primary completion2020-05-20Stopped2020-10-16Results posted2021-07-07

Vital statistics

Status
Terminated
Phase
Phase 1, Phase 2
Sponsor
Johns Hopkins University
Sponsor type
University, hospital or other
Conditions
HIV Dementia; HIV-Associated Cognitive Motor Complex
Interventions
Insulin, intranasal; Placebo, intranasal
Participants
21
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.